ATRC Stock Price, Chart, Stats & News

AtriCure, Inc.
Save
1.44B
Market cap
–
Current P/E
357.14x
Forward P/E
ATRC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 74.84% |
Operating margin | -1.58% |
Pretax margin | -1.90% |
Net margin | -2.14% |
Effective tax rate | -12.64% |
ROA | -1.75% |
ROE | -2.43% |
D/E | 0.18x |
Interest coverage ratio | -1.15x |
ATRC valuation
P/E | – |
P/S | 2.69x |
P/B | 2.82x |
P/CF | 24.16x |
P/FCF | 29.79x |
P/OCF | 24.16x |
PEG | -1.99x |
EV multiple | 129.32x |
About
AtriCure, Inc. creates, produces, and markets medical devices for the surgical treatment of cardiac tissue and intercostal nerves. Its market reach spans the United States, Europe, Asia, and other international territories. The company's product line features various ablation technologies.
Similar securities
Based on sector and market capitalization
Report issue











